Head-to-Head

Ginkgo Bioworks Holdings, Inc. vs. Halozyme Therapeutics, Inc.

DNA

Ginkgo Bioworks Holdings, Inc.

$8.44 +1.44%

VS HALO

Halozyme Therapeutics, Inc.

$93.09 +0.06%

Halozyme Therapeutics, Inc. (HALO) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

DNAHALO
Market Cap $539.34 million $10.61 billion

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

DNAHALO
Short Interest 19.24% 9.75%

HALO leads on 1 of 1 risk & sentiment factors.

Dig deeper: DNA overview, DNA financials, HALO overview, HALO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.